...
首页> 外文期刊>Journal of Virological Methods >Importance of the cutoff ratio for detecting antibodies against hepatitis A virus in oral fluids by enzyme immunoassay
【24h】

Importance of the cutoff ratio for detecting antibodies against hepatitis A virus in oral fluids by enzyme immunoassay

机译:酶免疫测定法检测唾液中甲型肝炎病毒抗体的临界值的重要性

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Multiple studies have examined the use of oral fluids in modified serum-based assays aiming to replace serum in antibody detection for hepatitis A. However, the reliable detection of HAV immunity in oral fluid requires an extremely sensitive assay; most immunoassays designed for serum antibody determination lack sufficient sensitivity for this purpose. Consequently, an "in-house" competitive enzyme immunoassay (EIA) designed specifically for use with oral samples collected using a ChemBio (R) device was developed to detect total anti-HAV antibodies (IgG and IgM). This system was compared to an in-house competitive EIA and a commercial EIA considered to be the "gold standard" using corresponding serum samples (n = 225) to determine the accuracy of the assay and to evaluate the importance of the cutoff ratio for the detection of anti-HAV antibodies in oral fluids. When the median serum cutoff and the optimal oral fluid cutoff (ROC analysis) obtained from the in-house competitive EIA were compared, the oral fluid cutoff was found to be 28.8% higher than the serum cutoff. When different oral fluid cutoff values were compared, a reduction of about 17% was shown to be essential to increase test accuracy. At an oral fluid cutoff value of 0.351, sensitivity and specificity were higher, reaching 91.7% and 86.2% (p < 0.001, AUROC = 0.915), respectively. The convenience, accuracy and non-invasive nature of the developed method make it a useful alternative to serum-based assays for discriminating between HAV-immune and non-immune individuals
机译:多项研究检查了口服液在改良的基于血清的测定中的用途,旨在取代血清来检测甲型肝炎的抗体。然而,可靠检测口服液中HAV免疫力需要极高的灵敏度;设计用于血清抗体测定的大多数免疫测定法均缺乏足够的灵敏度。因此,开发了专门设计用于与使用ChemBio装置收集的口服样品一起使用的“内部”竞争酶免疫测定法(EIA),以检测总的抗HAV抗体(IgG和IgM)。使用相应的血清样本(n = 225),将该系统与内部竞争性EIA和被认为是“金标准”的商业EIA进行比较,以确定测定的准确性并评估该标准的临界值的重要性。检测口腔液中的抗HAV抗体。当比较内部竞争性环境影响评估的中位血清截止值和最佳口服液截止值(ROC分析)时,发现口服液截止值比血清截止值高28.8%。当比较不同的口服液截留值时,减少大约17%的水显示对提高测试准确性至关重要。在0.351的口服液截止值下,敏感性和特异性更高,分别达到91.7%和86.2%(p <0.001,AUROC = 0.915)。所开发方法的便利性,准确性和非侵入性使其成为基于血清的检测方法的有用替代品,可用于区分HAV免疫和非免疫个体

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号